1-6 of 6
Nausheen Ahmed
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lisocabtagene Maraleucel for Relapsed/Refractory Large B-Cell Lymphoma: A Cell Therapy Consortium Real-World Analysis

Clinical Trials & Observations
Peter A. Riedell, Connor B. Grady, Loretta J. Nastoupil, Alejandro Luna De Abia, Nausheen Ahmed, Richard T. Maziarz, Marie Hu, Jamie Brower, Wei-Ting Hwang, Stephen J. Schuster, Andy I. Chen, Olalekan O. Oluwole, Veronika Bachanova, Joseph P. McGuirk, Miguel-Angel Perales, Michael R. Bishop, David L. Porter
Journal: Blood Advances
Blood Adv bloodadvances.2024014164.
https://doi.org/10.1182/bloodadvances.2024014164
Published: 2024
Includes: Supplemental data
Journal Articles

Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Related CRS and ICANS - A Multicenter Retrospective Analysis

Amneet Bajwa, Qiuhong Zhao, Marcus J Geer, Chenyu Lin, James Westholder, Joeseph Maakaron, Monalisa Ghosh, David G Frame, Ahmed Galal, Justin Tossey, Nausheen Ahmed, Evandro D Bezerra, Nathan Denlinger, Marcos J de Lima, Narendranath Epperla, Paolo F. Caimi, Timothy J Voorhees
Journal: Blood Advances
Blood Adv bloodadvances.2024013688.
https://doi.org/10.1182/bloodadvances.2024013688
Published: 2024
Journal Articles

Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel

Nausheen Ahmed, William Wesson, Forat Lutfi, David L. Porter, Veronika Bachanova, Loretta J. Nastoupil, Miguel-Angel Perales, Richard T. Maziarz, Jamie Brower, Gunjan L. Shah, Andy I. Chen, Olalekan O. Oluwole, Stephen J. Schuster, Michael R. Bishop, Joseph P. McGuirk, Peter A. Riedell
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5346–5354.
https://doi.org/10.1182/bloodadvances.2023012549
Published: 2024
Includes: Supplemental data
Journal Articles

CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma

Priyanka A. Pophali, Joshua A. Fein, Kwang W. Ahn, Molly Allbee-Johnson, Nausheen Ahmed, Farrukh T. Awan, Shatha Farhan, Natalie S. Grover, Talal Hilal, Madiha Iqbal, Joseph Maakaron, Dipenkumar Modi, Elham Nasrollahi, Levanto G. Schachter, Craig Sauter, Mehdi Hamadani, Alex Herrera, Roni Shouval, Mazyar Shadman
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5290–5296.
https://doi.org/10.1182/bloodadvances.2024013863
Published: 2024
Includes: Supplemental data
Journal Articles

Race and insurance: real-world insights on CAR-T outcomes

Nausheen Ahmed, Natalie S. Grover
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2589–2591.
https://doi.org/10.1182/bloodadvances.2024013148
Published: 2024
Journal Articles

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions

Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G. Karrison, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison M. Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas Bisneto, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J. Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4528–4538.
https://doi.org/10.1182/bloodadvances.2023010016
Published: 2023
Includes: Supplemental data